Table 3

Associations between urinary MCP-1 or HPSE-1 levels and albumin:creatinine ratio stratified by ethnicity

Unadjusted difference (95% CI)Model 1 difference (95% CI)Model 2 difference (95% CI)Model 3 difference (95% CI)Model 4 difference (95% CI)
Log MCP-1 (ng/mmol)
 Dutch0.73 (−0.02 to 1.47)0.73 (−0.02 to 1.48)0.70 (−0.12 to 1.53)0.77 (−0.04 to 1.58)0.77 (−0.05 to 1.59)
 South-Asian Surinamese1.40 (0.94 to 1.86) p<0.0011.42 (0.94 to 1.86) p<0.0011.35 (0.86 to 1.83) p<0.0011.02 (0.54 to 1.50) p<0.0011.03 (0.58 to 1.47) p<0.001
 African Surinamese1.11 (0.45 to 1.78) p=0.0011.14 (0.95 to 1.88) p=0.0011.19 (0.34 to 2.03) p=0.0011.25 (0.55 to 1.95) p=0.0011.23 (0.52 to 1.94) p=0.001
 Ghanaian0.67 (0.20 to 1.14) p=0.010.67 (0.22 to 1.11) p=0.0040.22 (−0.24 to 0.69)0.24 (−0.23 to 0.70)0.22 (−0.24 to 0.68)
 Turkish0.91 (0.23 to 1.59) p=0.010.88 (0.19 to 1.56) p=0.010.81 (0.14 to 1.49) p=0.020.87 (0.21 to 1.53) p=0.010.87 (0.27 to 1.47) p=0.01
 Moroccan0.70 (0.26 to 1.15) p=0.0020.64 (0.18 to 1.10) p=0.010.64 (0.17 to 1.11) p=0.010.63 (0.18 to 1.08) p=0.010.64 (0.22 to 1.07) p=0.004
Log HPSE-1 (mU/mmol)
 Dutch0.42 (0.10 to 0.74) p=0.010.43 (0.10 to 0.74) p=0.010.42 (0.03 to 0.77) p=0.020.40 (0.05 to 0.76) p=0.030.40 (0.04 to 0.76) p=0.03
 South-Asian Surinamese0.20 (−0.28 to 0.69)0.18 (−0.30 to 0.67)0.31 (−0.20 to 0.83)0.30 (−0.16 to 0.75)0.30 (−0.13 to 0.73)
 African Surinamese−0.04 (−0.57 to 0.50)−0.03 (−0.58 to 0.51)0.08 (−0.63 to 0.78)0.54 (−0.07 to 1.16)0.54 (−0.08 to 1.15)
 Ghanaian0.30 (−0.09 to 0.69)0.22 (−0.16 to 0.60)0.08 (−0.27 to 0.43)0.08 (−0.27 to 0.43)0.10 (−0.25 to 0.44)
 Turkish0.13 (−0.42 to 0.68)0.11 (−0.44 to 0.66)−0.06 (−0.68 to 0.56)0.10 (−0.56 to 0.75)−0.25 (−0.88 to 0.38)
 Moroccan0.15 (−0.19 to 0.50)0.12 (−0.22 to 0.47)0.18 (−0.21 to 0.57)0.21 (−0.16 to 0.58)0.23 (−0.13 to 0.58)
  • Linear regression analyses, p<0.05 is considered statistically significant.

  • Model 1: age and sex.

  • Model 2: +duration of diabetes, BMI, current smoking, hypertension, HbA1c and total cholesterol.

  • Model 3: +eGFR.

  • Model 4: +use of RAAS inhibitors.

  • ACR, albumin:creatinine ratio; BMI, body mass index; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HPSE-1, heparanase; MCP-1, monocyte chemoattractant protein-1; RAAS, renin-angiotensin-aldosterone system.